ORIGINAL PAPER
Association of nonalcoholic fatty liver with carotid intima-media thickness in patients with dyslipidaemia
More details
Hide details
Submission date: 2018-06-27
Final revision date: 2018-08-04
Acceptance date: 2018-09-25
Publication date: 2018-09-30
Medical Studies 2018;34(3):226-231
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in adults, which is associated with metabolic syndrome.
Aim of the research:
To investigate the association of fatty liver with carotid intima-media thickness (CIMT) in patients with dyslipidaemia.
Material and methods:
Fifty-two patients with uncomplicated NAFLD were enrolled. Sixty-four sex- and aged-match subjects without NAFLD were considered as controls. An ultrasound was performed in the supine and left lateral positions. In all patients, CIMT was measured by high-resolution real-time B-mode ultrasonography with a 7.5-MHz linear transducer. Data, including CIMT, plasma liver function tests, and other biochemical blood measurements, were collected.
Results:
The mean CIMT in cases (0.66 mm) was significantly greater than the controls (0.58 mm) (p = 0.003). The mean CIMT in patients with fatty liver grade III (0.71 mm) was significantly more than the patient with fatty liver grade II (0.65 mm) (p = 0.003). Older age, hypertension, diabetes, body mass index, and smoking were associated with increased CIMT.
Conclusions:
In patients with NAFLD and dyslipidaemia a significant increase in the CIMT has been observed compared to the control. So, it seems that performing liver ultrasound in patients with dyslipidaemia is reasonable, and in the presence of fatty liver, assessment of carotid atherosclerotic changes is recommended, which may lead to therapeutic intervention. Considering ultrasound as a noninvasive and non-ionising radiation imaging technique, as well as its low cost and availability, may make this method an ideal candidate for a diagnosis.
REFERENCES (18)
1.
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395.
2.
Palmieri VO, Grattagliano I, Portincasa P, Palasciano G. Systemic oxidative alterations are associated with visceraladiposity and liver steatosis in patients with metabolic syndrome. J Nutr 2006; 136: 3022-3026.
3.
Petit JM, Guiu B, Terriat B, Loffroy R, Robin I, Petit V, Bouillet B, Brindisi MC, Duvillard L, Hillon P, Cercueil JP, Verges B. Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. J Clin Endocrinol Metab 2009; 94: 4103-4106.
4.
Garg A, Misra A. Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab 2002; 87: 3019-3022.
5.
Ioannou GN, Weiss NS, Boyko EJ, Mozaffarian D, Lee SP. Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology 2006; 43: 1145-1151.
6.
Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005; 112: 2130-2137.
7.
Assy N, Djibre A, Farah R, Grosovski M, Marmor A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010; 254: 393-400.
8.
Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-728.
9.
Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
10.
Ishizaka N, Ishizaka Y, Yamakado M, Toda E, Koike K, Nagai R. Association between metabolic syndrome and carotid atherosclerosis in individuals without diabetes based on the oral glucose tolerance test. Atherosclerosis 2009; 204: 619-623.
11.
Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35: 898-904.
12.
Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
13.
Markus RA, Mack WJ, Azen SP, Hodis HN. Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness. Am J Clin Nutr 1997; 65: 1000-1004.
14.
Niu L, Zhang Y, Qian M, Meng L, Xiao Y, Wang Y, Liu X, Zheng R, Zheng H. Impact of multiple cardiovascular risk factors on carotid intima-media thickness and elasticity. PLoS One 2013; 8: e67809.
15.
Poanta LI, Albu A, Fodor D. Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. Med Ultrason 2011; 13: 215-219.
16.
Brea A, Mosquera D, Martín E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005; 25: 1045-1050.
17.
Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G, Arcaro G. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29: 1325-1330.
18.
Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008; 49: 600-607.